XML 39 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Description (Details)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Sep. 30, 2012
Sep. 30, 2012
OctoPlus N.V.[Member]
Subsequent Event [Member]
USD ($)
Sep. 30, 2012
OctoPlus N.V.[Member]
Subsequent Event [Member]
EUR (€)
Sep. 30, 2012
Vessix Vascular, Inc. [Member]
Subsequent Event [Member]
USD ($)
Description (Textual) [Abstract]        
Common stock offering price     € 0.52  
Expected gain on sale of investments   $ 0.1   $ 1.2
Proceeds on Sale of Investment at Maturity       $ 5.5
Description (Additional Textual) [Abstract]        
Minimum percentage of research & development revenue to aggregate revenue 10.00%